Liang Li

Liang has over 20 years of clinical and preclinical experience in drug development, of which more than 8 years he has been working in bio/pharmaceutical and medical device industry as a lead or consultant biostatistician.  He has extensive experience in design and analysis of Phase I to IV clinical trials and registries. He has participated in and led statistical efforts in multiple U.S. and international submissions, and the FDA Advisory Committee (Panel) Meetings.  He has diverse management experience for projects conducted in-house and by CROs, and   collaborated with expert statistical consultants, medical directors/principal investigators on key study design and publications.  He has deep understanding of FDA/EMEA/HC/PMDA and ICH guidelines, and their implementations.  He is more than happy to be part of your success by assisting you team with high quality services.

To know more about LLX Solutions or if you have any query please click here to contact us.